Fingerprint
Dive into the research topics of 'ATLANTIS: A Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically